| Analysis | Metabolite Name | Measured Value | Units | Feeding | Group |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 20181 | Peak area | Fed | HCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 21158 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 21362 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 21562 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 21568 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 22364 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 22920 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 23221 | Peak area | Fast | HCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 23431 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 23626 | Peak area | Fed | HCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 24235 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 24273 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 25053 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 25419 | Peak area | Fed | HCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 25561 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 26397 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 26501 | Peak area | Fed | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 26568 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 26842 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 27060 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 27106 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 27206 | Peak area | Fed | HCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 27210 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 27637 | Peak area | Fast | HCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 28419 | Peak area | Fast | HCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 28431 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 28668 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 29098 | Peak area | Fast | HCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 29605 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 29843 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 29889 | Peak area | Fast | HCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 30167 | Peak area | Fast | HCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 30412 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 31338 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 32613 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 32615 | Peak area | Fed | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 33601 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 33693 | Peak area | Fast | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 33726 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 34467 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 34723 | Peak area | Fed | HCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 35412 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 37452 | Peak area | Fast | LCR-AL |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 40251 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 41105 | Peak area | Fed | LCR-CR |
| Reversed phase NEGATIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M-H)- | 41879 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 5410 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 9833 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 10123 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 11787 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 11848 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 11904 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 12063 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 12084 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 13049 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 13117 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 13654 | Peak area | Fed | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 14724 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 14822 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 15392 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 15852 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 17228 | Peak area | Fed | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 18576 | Peak area | Fed | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 18866 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 19189 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 19206 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 19211 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 19299 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 19960 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 20628 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 21098 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 21317 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 23546 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 23612 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 25027 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 25770 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 26043 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 27444 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 27591 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 29250 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 32998 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 33371 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 35478 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 35613 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | 36032 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | Peak area | Fast | HCR-CR | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | Peak area | Fed | HCR-AL | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+H)+ | Peak area | Fed | HCR-CR | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 4430 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 6673 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 7386 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 8110 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 8327 | Peak area | Fed | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 9067 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 9439 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 10800 | Peak area | Fed | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 10984 | Peak area | Fed | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 11402 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 11746 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 11759 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 12149 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 12441 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 12524 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 12792 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 13184 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 13218 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 13566 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 13973 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 14272 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 14366 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 14390 | Peak area | Fast | HCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 14466 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 14468 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 14795 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 14815 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 15222 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 15382 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 15517 | Peak area | Fed | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 15986 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 16167 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 16393 | Peak area | Fed | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 16498 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 17913 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 17975 | Peak area | Fed | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 18233 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 18334 | Peak area | Fast | LCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 20923 | Peak area | Fast | HCR-CR |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 21279 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | 21934 | Peak area | Fast | LCR-AL |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Fast | HCR-CR | |
| Reversed phase POSITIVE ION MODE | N-ACETYLNEURAMINATE (CAS# 131-48-6); (M+NA)+ | Peak area | Fed | HCR-AL |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|